In addition, this study has preliminarily explored the mechanism by which anti‐CD41‐PLT‐VP16 alleviates HLH by decreasing macrophage activity and inhibiting hyperinflammatory responses. This evidence concerns the gene ITGA2B and hemophagocytic syndrome.